Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Our Strategic Road Map defines strategies, standards, and policy frameworks to support responsible global use of genomic and related health data.
Discover how a meeting of 50 leaders in genomics and medicine led to an alliance uniting more than 5,000 individuals and organisations to benefit human health.
GA4GH Inc. is a not-for-profit organisation that supports the global GA4GH community.
To guide our collaborative, globe-spanning alliance, GA4GH relies on a Standards Steering Committee and an Executive Committee.
The Funders Forum brings together organisations that offer both financial support and strategic guidance.
The EDI Advisory Group responds to issues raised in the GA4GH community, finding equitable, inclusive ways to build products that benefit diverse groups.
Distributed across four Host Institutions, our staff team supports the mission and operations of GA4GH.
Curious who we are? Meet the people and organisations across six continents who make up GA4GH.
More than 500 organisations connected to genomics — in healthcare, research, patient advocacy, industry, and beyond — have signed onto the mission and vision of GA4GH as Organisational Members.
These core Organisational Members are genomic data initiatives that have committed resources to guide GA4GH work and pilot our products.
This subset of Organisational Members whose networks or infrastructure align with GA4GH priorities has made a long-term commitment to engaging with our community.
Local and national organisations assign experts to spend at least 30% of their time building GA4GH products.
Anyone working in genomics and related fields is invited to participate in our inclusive community by creating and using new products.
Wondering what GA4GH does? Learn how we find and overcome challenges to expanding responsible genomic data use for the benefit of human health.
Study Groups define needs. Participants survey the landscape of the genomics and health community and determine whether GA4GH can help.
Work Streams create products. Community members join together to develop technical standards, policy frameworks, and policy tools that overcome hurdles to international genomic data use.
GIF solves problems. Organisations in the forum pilot GA4GH products in real-world situations. Along the way, they troubleshoot products, suggest updates, and flag additional needs.
NIF finds challenges and opportunities in genomics at a global scale. National programmes meet to share best practices, avoid incompatabilities, and help translate genomics into benefits for human health.
Communities of Interest find challenges and opportunities in areas such as rare disease, cancer, and infectious disease. Participants pinpoint real-world problems that would benefit from broad data use.
Find out what’s happening with up to the minute meeting schedules for the GA4GH community.
See all our products — always free and open-source. Do you work on cloud genomics, data discovery, user access, data security or regulatory policy and ethics? Need to represent genomic, phenotypic, or clinical data? We’ve got a solution for you.
All GA4GH standards, frameworks, and tools follow the Product Development and Approval Process before being officially adopted.
Learn how other organisations have implemented GA4GH products to solve real-world problems.
Help us transform the future of genomic data use! See how GA4GH can benefit you — whether you’re using our products, writing our standards, subscribing to a newsletter, or more.
Help create new global standards and frameworks for responsible genomic data use.
Align your organisation with the GA4GH mission and vision.
Want to advance both your career and responsible genomic data sharing at the same time? See our open leadership opportunities.
Join our international team and help us advance genomic data use for the benefit of human health.
Share your thoughts on all GA4GH products currently open for public comment.
Solve real problems by aligning your organisation with the world’s genomics standards. We offer software dvelopers both customisable and out-of-the-box solutions to help you get started.
Learn more about upcoming GA4GH events. See reports and recordings from our past events.
Speak directly to the global genomics and health community while supporting GA4GH strategy.
Be the first to hear about the latest GA4GH products, upcoming meetings, new initiatives, and more.
Questions? We would love to hear from you.
Read news, stories, and insights from the forefront of genomic and clinical data use.
Attend an upcoming GA4GH event, or view meeting reports from past events.
See new projects, updates, and calls for support from the Work Streams.
Read academic papers coauthored by GA4GH contributors.
Listen to our podcast OmicsXchange, featuring discussions from leaders in the world of genomics, health, and data sharing.
Check out our videos, then subscribe to our YouTube channel for more content.
View the latest GA4GH updates, Genomics and Health News, Implementation Notes, GDPR Briefs, and more.
Discover all things GA4GH: explore our news, events, videos, podcasts, announcements, publications, and newsletters.
10 Jun 2022
A policy from the GA4GH Data Access Committee Review Standards (DACReS) group aims to harmonise the processes of data access committees, prevent inconsistencies in the review process and ensure proper access to genomic data.
For science to advance, researchers need access to the growing troves of data around the world. Robust access procedures can lead to increased transparency and research reproducibility. But for genomic and health data, greater access has the potential for personal health information to be exploited for unintended purposes and carries a greater risk of misuse. Such a risk of data misuse can create distrust between the scientific community and the public and erodes participants’ privacy. To avoid this outcome, data access committees, commonly referred to as DACs, review and manage who can access genomic data.
DACs steward genomic data with two primary considerations: one is determining whether researchers may access data, and another is protecting participant interests. They are the gatekeepers and guardians of data.
“DACs are supervised by their institutions and organisations. However, they also abide by jurisdictional policies and frameworks that are already in place to ensure ethical and responsible data sharing,” said Jonathan Lawson, the Data Use and Researcher Identities (DURI) workstream’s Data Use co-lead, and senior software product manager at the Broad Institute of MIT and Harvard. “They allow researchers to request data that was originally collected for one study to be used in subsequent studies.”
Like research ethics committees (also known as institutional review boards), DACs are comprised of teams of multidisciplinary experts; but they also tend to have different operating procedures and policies that they rely on to make their decisions. This can sometimes lead to inconsistencies in approach and access to genomic data both within a DAC and across different datasets in organisations. This can thwart otherwise important uses of genomic data to drive research discovery and medical breakthroughs. Both under- and over-protecting access to genomic data can undermine participants’ interests, many of whom want their data to be used for public benefit, albeit in a responsible manner and aligned with their initial consent to provide their data in the first place.
In order to ensure that data access requests are met with consistent review criteria, the Global Alliance for Genomics & Health (GA4GH) formed a working group to review and streamline Data Access Committee Review Standards (DACReS) around the world. Intended to unify processes across DACs and data access requests, the group has now published its first product: the GA4GH Data Access Committee Guiding Principles and Procedural Standards.
The genomic data access process can be a tedious one. Normally, researchers request data access by submitting a thoroughly-detailed application to a DAC. The DAC will then meticulously review the request. This includes ensuring that the researcher and the research team are qualified to access and analyse the genomic data; it also includes an assessment of whether the request aligns with the underlying data use terms derived from the participants’ consent. Applicants must respond to issues that arise at each point.
Upon a review by the DAC of an access request, one of three outcomes can arise: the applicant is granted access to the data set, the application is subject to further clarifications from the applicant before it can be approved, or the application is rejected.
The DACReS policy on Data Access Committee Guiding Principles and Procedural Standards lays out specific guidance for DACs, with what are considered “essential” and “desired” criteria for their procedural standards. These principles and standards aim to create an efficient, fair, consistent, and robust review process across DACs globally.
The new policy acts on the GA4GH mission to accelerate genomic research while respecting the interests of participants from whom data are ultimately sourced. The procedural standards offer DACs a roadmap for creating standard operating procedures, committee terms of reference, access request procedures, data leak solutions, progress reporting, and policy implementation.
In addition to being promoted as a much-needed, detailed standard for DACs, the DACReS policy is also anticipated to be seen as a helpful guide for DACs to integrate their work with other GA4GH standards, like the Data Use Ontology, Passports, and Machine-Readable Consent Guidance. These and other deliverables help ensure responsible access to genomic data distributed around the globe.
“Realising that the focus of the DACReS workgroup at this stage ought to be on procedural standards, as this an important first step to achieving greater harmonisation of DACs, we set a series of planned deliverables in due course, similar to how things have been done across other projects within GA4GH,” said Edward Dove, a Lecturer in Health Law and Regulation at the University of Edinburgh, and with Lawson and Vasiliki Rahimzadeh, a co-lead of the DACReS workgroup (a collaboration between members of the DURI WS and the Regulatory and Ethics WS).
“The group’s next steps are to study the uptake of this policy in DACs worldwide, and periodically revisit the guidance as technology and regulation evolve over time. We anticipate that several of our Driver Projects, some of which are involved within the DACReS group, will take up these guiding principles and procedural standards and let us know how it’s impacting the quality and effectiveness of their genomic data access review process,” said Vasiliki Rahimzadeh, an incoming Assistant Professor at Baylor College of Medicine in Houston, Texas.
To help drive the development of future deliverables, the DACReS workgroup is currently surveying DAC members globally about their operations and membership. The joint team invites all members to contribute to their 20-minute research survey.